Showing results (1211-1220 of 5,695) with videos related to

Sort By:
Pageof 570
The Oncologist|February 6, 2026
Third-line treatment decision-making for mCRC: a cross-sectional survey of US community physiciansChristopher Cann, Sophia Zhao, Nadeem Khan, et al.
The Oncologist|February 6, 2026
Tumor suppressor genes, treatments, and survival in US veterans with prostate cancerKrishny Karunanandaa, Eric Marshall Knoche, Robert Bruce Montgomery, et al.
The Oncologist|February 15, 2026
Outcomes after SRS and Ipilimumab plus Nivolumab for Melanoma Brain Metastases Following Prior Immune Checkpoint Inhibitor or Targeted TherapyIan Messing, Lauren Linkowski, Matthew D Riina, et al.
The Oncologist|January 26, 2026
A prospective post-marketing observational study of abemaciclib in patients with HR+, HER2- breast cancer in ChinaQuchang Ouyang, Peng Yuan, Jianxia Liu, et al.
The Oncologist|February 6, 2026
Efficacy of neoadjuvant endocrine therapy with CDK4/6 inhibitors in locally advanced breast cancerMengqi Zhang, Mingxiao Li, Shihan Zhou, et al.
The Oncologist|December 15, 2025
Precision targeted-immunotherapy for BRAF V600E and MET-amplified biliary tract cancer: two case reportsXin He, Sidong Xie, Changchang Jia, et al.
The Oncologist|December 15, 2025
Recurrent Hematological Toxicity After Second-Line Treatment in Patients with Glioblastoma: Indication of a Potential PredispositionLeon van Hout, Femke E L van den Elzen, Zoë de Jong, et al.
The Oncologist|November 20, 2025
In vitro drug sensitivity and clinical efficacy of the HAG regimen in pediatric AMLDiying Shen, Weiling Yan, Tian Xia, et al.
The Oncologist|December 2, 2025
Complete response following trastuzumab-deruxtecan in a man with HER2-overexpressing metastatic, poorly differentiated scrotal carcinomaMia Hofstad, Jie Zheng, Isamu Tachibana, et al.
The Oncologist|December 25, 2024
Outcomes and molecular profiles in sarcomatoid carcinoma of unknown primary: the Mayo Clinic experienceHarry E Fuentes, Riham Suleiman, Rondell P Graham, et al.
Pageof 570